摘要:
A device for demodulating position information that is recorded as track wobbling in a record medium by a BPSK scheme includes a carrier-wave-generation circuit which derives a carrier wave from a wobbling signal obtained from the record medium, a phase-adjustment circuit which generates a phase-comparison signal having a 90° phase difference relative to the carrier wave, a multiplier which multiplies the wobbling signal and the phase-comparison signal to supply a product signal, and a detection circuit which detects a phase error of the carrier wave introduced by the carrier-wave-generation circuit by detecting the phase error between the wobbling signal and the phase-comparison signal based on the product signal.
摘要:
A reference clock frequency divider feasible for a motor drive IC (Integrated Circuit), optical disk drive, hard disk drive or similar apparatus. The frequency divider is capable of setting not only integral frequency division ratios but also decimal frequency division ratios without any circuit modification.
摘要:
An wobble signal detection circuit that is provided on an optical disk device and can detect a wobble signal having high accuracy and stability at least when recording information on an optical disk. This wobble signal detection circuit can be applied to plural types of optical recording media. With the wobble signal detection circuit, during a period for forming a space region, a first voltage signal provided from a first light receiving element is sampled and amplified to be a target voltage, a second voltage signal provided from a second light receiving element is sampled and amplified to be the target voltage. The difference between the two amplified signals are output as the wobble signal. The first and second light receiving elements are divided from each other in the direction tangential to a recording region on the optical recording medium.
摘要:
A device for demodulating position information that is recorded as track wobbling in a record medium by a BPSK scheme includes a carrier-wave-generation circuit which derives a carrier wave from a wobbling signal obtained from the record medium, a phase-adjustment circuit which generates a phase-comparison signal having a 90° phase difference relative to the carrier wave, a multiplier which multiplies the wobbling signal and the phase-comparison signal to supply a product signal, and a detection circuit which detects a phase error of the carrier wave introduced by the carrier-wave-generation circuit by detecting the phase error between the wobbling signal and the phase-comparison signal based on the product signal.
摘要:
The present invention provides a novel fructose responsive transcription control cis-element and a transcriptional regulatory factor that interacts therewith, a non-human animal having them transferred or inactivated, a diagnostic method for genetic susceptibility to a metabolic disorder using them, and a screening method for a prophylactic or therapeutic drug for a metabolic disorder using them.
摘要:
The present invention relates to an azole compound represented by the formula [I] wherein W is S or O; R is —COOR7, —X1-A1-COOR7 (R7 is H, alkyl) or tetrazolyl; R1, R2, R3 and R4 are H and the like; A is —(CH2)m—X— (X is —N(R8)—, —C(R9)(R10)—, —CO— or —CO—N(R8)—); B is aryl or aromatic heterocyclic group; R5 is H and the like; R6 is —(Y)s1-(A2)s-Z (Y is —O—, —S(O)t—, —N(R13)—, —N(R14)—CO—, —N(R14)—SO2—, —SO2—N(R14)— and the like, A2 is alkylene, and Z is cycloalkyl, aryl, aromatic heterocyclic group, indanyl, piperazinyl, a prodrug thereof or a pharmaceutically acceptable salt thereof. The compound [I] of the present invention has a protein tyrosine phosphatase 1B inhibitory activity, and is useful as a therapeutic agent for diabetes, a therapeutic drug for diabetic complications or a therapeutic drug for hyperlipidemia.
摘要:
The present invention provides an optical pickup device that is resistant to noise in a signal or an RF signal outputted from each light receiving member. Current signals outputted from the light receiving members are converted into voltage signals by I/V converters. The voltage signals are then added up by an adder, and then the added voltage signal is attenuated by an attenuator, so as to obtain an RF signal having the same signal level as the voltage signal outputted from each I/V converter. The RF signal is then transmitted from the optical pickup device to a circuit substrate through a signal line.
摘要:
A trial writing operation is performed on a phase-change optical disc using write and erase light-emitting powers, which together are varied according to predetermined variation ratios respectively. Signals relevant to said trial writing operation are reproduced from said disc. Optimum ones of the write and erase light-emitting powers are determined using the thus-reproduced signals. The predetermined variation ratios for the write and erase light-emitting powers may be the same as each other. Alternatively, the trial writing operation may be performed on a phase-change optical disc using write and erase light-emitting powers which are individually varied according to predetermined variation ratios respectively.
摘要:
Disclosed are: a method for detecting (diagnosing) visceral obesity in a subject; a test agent useful for the method; a method for searching for a substance that can be used as an active ingredient for ameliorating visceral obesity; and an ameliorating agent for visceral obesity or a medicinal agent for preventing a metabolic disease developed as a result of the progression of visceral obesity. As the test agent, a polynucleotide which comprises at least 15 nucleotides and can hybridize with a nucleotide sequence for coiled-coil domain containing protein 3 (CCDC3) gene or a nucleotide sequence complementary to the nucleotide sequence under stringent conditions or an antibody capable of recognizing CCDC3 protein is used.
摘要:
Disclosed are: a method for detecting (diagnosing) visceral obesity in a subject; a test agent useful for the method; a method for searching for a substance that can be used as an active ingredient for ameliorating visceral obesity; and an ameliorating agent for visceral obesity or a medicinal agent for preventing a metabolic disease developed as a result of the progression of visceral obesity. As the test agent, a polynucleotide which comprises at least 15 nucleotides and can hybridize with a nucleotide sequence for coiled-coil domain containing protein 3 (CCDC3) gene or a nucleotide sequence complementary to the nucleotide sequence under stringent conditions or an antibody capable of recognizing CCDC3 protein is used.